Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

ImmunoCellular Therapeutics, Ltd. (IMUC)

Add IMUC Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 6/22/2017 7:56:45 PM - Followers: 137 - Board type: Free - Posts Today: 2




ImmunoCellular Therapeutics continues to make significant progress in meeting important goals and positioning the company for success. We believe that our cancer vaccine platform has the potential to be transformative in the treatment of cancer, and to create value for all our stakeholders. Our goal is to build ImmunoCellular into a leading, independent commercial-stage cancer immunotherapy company.

Our dendritic cell (DC) vaccine technology and advanced manufacturing offer several advantages over earlier-generation cellular immunotherapies:

- Matured DCs secrete IL12, which is critical for stimulating T cell killing of cancer cells.
More than 80% of the final manufactured product consists of matured DCs.

- Unlike other cell-based vaccines, our DCs target multiple antigens, thus increasing the likelihood of effective treatment.

- Advanced manufacturing enables production of at least 20 doses of vaccine from a single apheresis (blood collection); thus patients do not need to undergo additional apheresis procedures.

- Compared to the only approved cell-based immunotherapy, our DC vaccines can be manufactured at a significantly reduced cost.

- Ability to freeze and store vaccine for months or years eliminates the need to administer to the patient shortly after manufacture.
- Intradermal administration route reduces the time and inconvenience of intravenous infusion for both patient and physician.

Company Information:

21900 Burbank, 3rd Floor
Woodland Hills, CA 91367

Phone: 818-992-2907 



Press Releases:



Transfer Agent:

U.S. Stock Transfer Corp.
Suite 200
Glendale, CA 91204-2991

 Investor Relations:

Gary Nash, CEOcast, Inc.

Tel: (212)732-4300




ImmunoCellular has concluded a phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular's pipeline also includes: ICT-121, a dendritic cell vaccine targeting CD133; ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells; and the Stem-to-T-cell research program which engineers the patient's hematopoietic stem cells to generate antigen-specific cancer killing T-cells.

Announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM). This agreement with PharmaCell, a leading European contract manufacturing organization focuses on the production of human cell therapy products, and is designed to enable ImmunoCellular to access phase 3 supplies of ICT-107, manufactured with ImmunoCellular's commercial-ready production process. ImmunoCellular intends to initiate a Phase 3 registrational program for ICT-107 in the US and in Europe in 2015

>>> What these CANCER vaccines could be worth


Investor Presentation -> 





Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IMUC News: Current Report Filing (8-k) 04:17 PM
IMUC News: Current Report Filing (8-k) 06/21/2017 05:28:29 PM
IMUC News: ImmunoCellular Therapeutics Provides Update on Strategic Review and Decision to Suspend Further Patient Randomization for ICT... 06/21/2017 06:00:00 AM
IMUC News: ImmunoCellular Therapeutics to Present at Marcum MicroCap Conference on June 15, 2017 06/12/2017 04:05:00 PM
IMUC News: Securities Registration Statement (s-1/a) 06/12/2017 08:31:01 AM
News News Alert: Current Report Filing (8-k) 06/22/2017 04:17:36 PM
#3646   Impressive with potential unable to support it with Investor100 06/22/17 07:56:45 PM
#3645   What about the science? redspinelpinktopaz 06/22/17 12:05:49 PM
#3644   Management incompetence at its worst! Investor100 06/21/17 10:17:10 PM
#3643   TWO years later and THE INEVITABLE was predicted maverick_1 06/21/17 12:01:24 PM
#3642   maverick_1 06/12/17 06:14:10 PM
#3641   I have just been hovering around Maverick. Doktornolittle 06/12/17 05:33:17 PM
#3640   Since $24/shr I've railed against $ into IMUC maverick_1 06/12/17 05:18:35 PM
#3639   WT%#*@&? They just diluted 60% or something Doktornolittle 06/12/17 09:46:22 AM
#3638   ASCO IMUC ICT-121on recurGBM Ph 1 results BUT maverick_1 06/07/17 09:49:39 AM
#3637   DETONATION is @1/2 way mark: No later than maverick_1 05/29/17 09:58:34 AM
#3635   Aren't you the happy one. cdaniel394 05/15/17 09:02:49 PM
#3634   cdaniel394 and this whole board of FAULTY posters maverick_1 05/15/17 07:21:20 PM
#3633   All of the lawsuits go back to that cdaniel394 05/09/17 11:13:37 AM
#3632   No idea, other than everyone and their mother mypekeispooped 05/09/17 11:04:33 AM
#3631   Thump, thump-------thump, thump! Where is all of the cdaniel394 05/09/17 10:51:43 AM
#3630   Anyone still alive here? mypekeispooped 05/09/17 10:43:12 AM
#3629   Looks like Manish's problem. IMUC only had to cdaniel394 04/10/17 05:01:42 PM
#3628   Perhaps because of its SEC problem: janice shell 04/10/17 01:15:33 PM
#3627   Looks like pulse lost again. N_B 03/06/17 02:12:49 PM
#3626   Pulse found? cdaniel394 03/06/17 01:19:11 PM
#3625   Trading - +12.5% today! Investor100 03/06/17 09:46:13 AM
#3624   Trading Halted Investor100 03/06/17 09:35:30 AM
#3623   ImmunoCellular Therapeutics Provides Update on ICT-107 Phase 3 Investor100 03/06/17 09:19:50 AM
#3622   Is this setting up to be one of cdaniel394 02/24/17 11:00:28 AM
#3621   How come? cdaniel394 02/14/17 08:15:33 PM
#3620   Should test the $4 area tomorrow togmaster 02/14/17 08:01:56 PM
#3619   Huge spike 45% Tdash 02/14/17 03:23:59 PM
#3618 [SMART MONEY] 01/11/17 08:21:13 AM
#3617   Bio Post reverse split Low floaters Are flying. That's why. Penny Gold Mine 01/10/17 07:27:45 PM
#3616   Thanks imuc These low floaters going nuts Penny Gold Mine 01/10/17 07:26:28 PM
#3615   I wonder when Claytrader will show up with cdaniel394 01/10/17 07:15:20 PM
#3614   IMUC @ Stockcharts Investor100 01/10/17 06:01:56 PM
#3613   I didn't see this till now, but nice call...! deniseann 01/10/17 05:52:15 PM
#3612   The only thing anyone can really do is deniseann 01/10/17 05:47:09 PM
#3611   It's hard to catch these kind of jumps deniseann 01/10/17 05:36:31 PM
#3610   I called the company a few minutes ago dlangend_02 01/10/17 05:05:11 PM
#3609   Still no news? cdaniel394 01/10/17 04:40:23 PM
#3608   Who knows? Can't find anything anywhere. I like cdaniel394 01/10/17 04:04:31 PM
#3607   That is the million dollar question. Hopefully?? Murocman murocman 01/10/17 04:03:11 PM
#3606   Whoa! What's going on here? Up 90% TiltMyBrain 01/10/17 03:59:12 PM
#3605   Imuc! Let's go! beebop_rocksteady 01/04/17 04:49:48 AM
#3604   S-1 filed. ktcougar 12/28/16 09:17:17 AM
#3603   Stockcharts @ IMUC Investor100 12/21/16 03:55:45 PM
#3602   IMUC Zika vaccine.nice., P3 ongoing. i see ash111 12/14/16 10:38:15 AM
#3601   3 Full weeks later from 11/21 post and maverick_1 12/09/16 10:12:13 PM
#3600   Honestly and sadly, NEVER FUN to post on maverick_1 11/21/16 04:38:43 PM
#3599   Having fun on this board??? TiltMyBrain 11/21/16 04:19:57 PM
#3598   I'm less optimistic than you may think for dlangend_02 11/21/16 03:43:50 PM
#3597   Let's see if this News does not have maverick_1 11/21/16 03:21:35 PM
#3596   Reverse split lol stock1ace1 11/21/16 11:03:31 AM